Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05396144

Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?

Evaluation of Nitrous Oxide Use in GI Endoscopy Procedures: Potential for Optimizing Sedation and Minimizing Side-Effects During Recovery

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Nitrous oxide (commonly known as 'laughing gas') is often used during dental and other outpatient procedures, because it is easy to administer, is short-acting and rapidly clears from the body following the procedure. The investigators hypothesize that use of Nitrous oxide during GI endoscopy may enhance patient comfort during the procedure and speed-up post-procedure recovery, while minimizing the fatigue and mental fogginess some patients report the day after receiving standard sedative and narcotic drugs used routinely for the procedure. The investigators are interested in determining if adding Nitrous Oxide to commonly used sedation drugs will decrease fatigue, mental fogginess, and nausea/vomiting, as well as determine when the patient felt fully recovered from the effects of all sedatives given for the procedure.

Conditions

Interventions

TypeNameDescription
DRUG5% inhaled nitrous oxide5% Nitrous oxide will be administered by face or nasal mask to be inhaled by the patient
DRUG50% inhaled nitrous oxide50% Nitrous oxide will be administered by face or nasal mask to be inhaled by the patient

Timeline

Start date
2024-05-01
Primary completion
2025-08-31
Completion
2025-08-31
First posted
2022-05-31
Last updated
2026-03-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05396144. Inclusion in this directory is not an endorsement.